The German/Dutch phase 3 ROBOT-2 trial demonstrated higher median lymph-node yield (36 vs 32) with robotic versus laparoscopic minimally invasive esophagectomy with no difference in surgical complications or cancer outcomes thus far. | Berlth, JAMA Surg 2026
